Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04263025 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

StatusActive, Not Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v12
  2. Primary and study completion dates: Oct 1, 2026 to Apr 1, 2027v11
  3. Primary and study completion dates: Oct 1, 2025 to Oct 1, 2026v10
  4. Re-verified, no change to tracked fieldsv9
  5. Primary and study completion dates: Oct 1, 2024 to Oct 1, 2025v8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 2 to 1v7
  2. Phase: Not applicable to Phase 2/3v6 Show 5 more changesShow less
    • Primary completion date: Apr 1, 2023 to Oct 1, 2024
    • Study completion date: Apr 1, 2024 to Oct 1, 2024
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: 6 to 29
    • Site details revised at 1 of 2 sites
  3. Site details revised at 1 of 2 sitesv5
  4. Primary completion date: Apr 1, 2022 to Apr 1, 2023
    • Study completion date: Apr 1, 2023 to Apr 1, 2024
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Study description shortened, about 7 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims at evaluating if placement of CLARIX® CORD 1K during robotic prostatectomy decreases the time to achieve complete erectile and urinary function after the surgery. As part of the study, the patient will be asked to answer various questions after the surgery regarding sexual and urinary function.
Trial Details
NCT Number NCT04263025
Lead Sponsor Hackensack Meridian Health
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov